Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.
Grant R Drummond, Stavros Selemidis, Kathy K Griendling, Christopher G Sobey
Index: Nat. Rev. Drug Discov. 10 , 453-471, (2011)
Full Text: HTML
Abstract
NADPH oxidases are a family of enzymes that generate reactive oxygen species (ROS). The NOX1 (NADPH oxidase 1) and NOX2 oxidases are the major sources of ROS in the artery wall in conditions such as hypertension, hypercholesterolaemia, diabetes and ageing, and so they are important contributors to the oxidative stress, endothelial dysfunction and vascular inflammation that underlies arterial remodelling and atherogenesis. In this Review, we advance the concept that compared to the use of conventional antioxidants, inhibiting NOX1 and NOX2 oxidases is a superior approach for combating oxidative stress. We briefly describe some common and emerging putative NADPH oxidase inhibitors. In addition, we highlight the crucial role of the NADPH oxidase regulatory subunit, p47phox, in the activity of vascular NOX1 and NOX2 oxidases, and suggest how a better understanding of its specific molecular interactions may enable the development of novel isoform-selective drugs to prevent or treat cardiovascular diseases.
Related Compounds
Related Articles:
2015-01-01
[PLoS ONE 10(1) , e0117842, (2015)]
The role of free radical generation in increasing cerebrovascular permeability.
2011-09-01
[Free Radic. Biol. Med. 51 , 967-977, (2011)]
Spectrofluorometric analysis of CYP2A6-catalyzed coumarin 7-hydroxylation.
2006-01-01
[Methods Mol. Biol. 320 , 91-6, (2006)]
Application of the ovarian teratoma mapping method in the mouse.
1983-04-01
[Genetics 103(4) , 797-812, (1983)]
Genetic analysis of alpha 4 integrin functions in the development of mouse skeletal muscle.
1996-11-01
[J. Cell Biol. 135(3) , 829-35, (1996)]